Australian scientists are working to improve medical devices for lung cancer treatment, sharing the outcome of their recent study in ‘ Incorporating Chemotherapeutic Drug into a Personalizable Silicone Airway Stent for the Treatment of Lung Cancer and Tracheobronchomalacia .’

 .

With a focus on relieving serious symptoms like central airway obstruction (CAO), the research team experimented with 3D printing molds to produce drug-eluting personalized airway stents, incorporated with chemotherapy drugs like Paclitaxel that inhibit the growth of cancer cells. Interior view of current Y-stents used today, including the metallic Wallstent™ [A] and the Novatech® Dumon™ silicone stent [B] used in many CAO treatments, which do not correlate well with unique patient airway geometries [C].

 .

Because diseases like lung cancer may leave patients struggling to breathe, pharmaceutical treatments and the use of effective devices can be critical to the quality of their lives—and even saving them in some cases. The researchers […]

Click here to view original web page at 3dprint.com